• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与视网膜静脉阻塞相关的黄斑水肿的解剖学生物标志物。

Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion.

机构信息

Clearside Biomedical, Alpharetta, Georgia.

Clearside Biomedical, Alpharetta, Georgia.

出版信息

Ophthalmol Retina. 2022 Dec;6(12):1206-1220. doi: 10.1016/j.oret.2022.06.016. Epub 2022 Jun 30.

DOI:10.1016/j.oret.2022.06.016
PMID:35781069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9927025/
Abstract

PURPOSE

To assess the relationship between best-corrected visual acuity (BCVA) and anatomic features in patients with macular edema (ME) related to retinal vein occlusion (RVO).

DESIGN

Post hoc analysis of 3 clinical trials, which included verified diagnoses, protocol refractions, and the assessment of OCT and fluorescein angiography (FA) images at a masked reading center.

PARTICIPANTS

Patients diagnosed with RVO-ME.

METHODS

Correlation analyses were performed to determine the correlation between BCVA and macular anatomy at baseline and at 12 and 24 weeks and between changes from baseline to 12 and 24 weeks.

MAIN OUTCOME MEASURES

The correlations between BCVA and central subfield thickness (CST), ellipsoid zone (EZ) integrity, intraretinal fluid (IRF), subretinal fluid, central leakage, and ischemia were assessed.

RESULTS

In a total of 828 eyes with RVO-ME, the mean age, BCVA, and CST at baseline was 64.7 years, 51.1 letters, and 656.9 μm, respectively. At baseline, a moderate negative correlation was observed between BCVA and CST (r = - 0.56, P < 0.001). At weeks 12 and 24, the mean BCVA of eyes with definitely abnormal (absent) EZ was statistically significantly worse than that of eyes with normal EZ. At week 12, a moderate negative correlation was observed between changes in BCVA and changes in CST (r = - 0.35, P < 0.001), with a similar degree of association noted at week 24 (r = - 0.35, P < 0.001). At weeks 12 and 24, eyes that showed any improvement in central IRF showed a greater improvement in BCVA than eyes that showed no improvement worsening (week 12: 463 eyes, 18.3 letters vs. 177 eyes, 13.0 letters, respectively, P < 0.001) and (week 24: 332 eyes, 20.2 letters vs. 131 eyes, 13.3 letters, respectively, P < 0.001). With respect to the correlation between baseline BCVA and fluorescein leakage or capillary nonperfusion, the Pearson correlation coefficients were - 0.41 (P < 0.001) and - 0.16 (P = 0.060), respectively.

CONCLUSIONS

In addition to CST, there are important clinically relevant relationships between BCVA and both OCT and FA anatomic features in patients with RVO-ME.

摘要

目的

评估与视网膜静脉阻塞(RVO)相关的黄斑水肿(ME)患者的最佳矫正视力(BCVA)与解剖特征之间的关系。

设计

3 项临床试验的事后分析,其中包括已确诊的病例、方案屈光度以及在盲法阅读中心评估 OCT 和荧光素血管造影(FA)图像。

参与者

被诊断为 RVO-ME 的患者。

方法

进行相关分析,以确定基线时、第 12 周和第 24 周时 BCVA 与黄斑解剖结构之间的相关性,以及从基线到第 12 周和第 24 周的变化之间的相关性。

主要观察指标

评估 BCVA 与中心视网膜下厚度(CST)、椭圆体带(EZ)完整性、视网膜内液(IRF)、视网膜下液、中心渗漏和缺血之间的相关性。

结果

在总共 828 只患有 RVO-ME 的眼中,平均年龄、基线时的 BCVA 和 CST 分别为 64.7 岁、51.1 个字母和 656.9μm。在基线时,BCVA 与 CST 之间存在中度负相关(r = -0.56,P < 0.001)。在第 12 周和第 24 周时,EZ 明显异常(缺失)的眼的平均 BCVA 明显差于 EZ 正常的眼。在第 12 周时,BCVA 的变化与 CST 的变化之间存在中度负相关(r = -0.35,P < 0.001),第 24 周时也观察到类似程度的相关性(r = -0.35,P < 0.001)。在第 12 周和第 24 周时,中央 IRF 有任何改善的眼的 BCVA 改善程度大于没有改善或恶化的眼(第 12 周:463 只眼,18.3 个字母与 177 只眼,13.0 个字母,分别,P < 0.001)和(第 24 周:332 只眼,20.2 个字母与 131 只眼,13.3 个字母,分别,P < 0.001)。关于基线时 BCVA 与荧光素渗漏或毛细血管无灌注之间的相关性,Pearson 相关系数分别为 -0.41(P < 0.001)和 -0.16(P = 0.060)。

结论

除 CST 外,RVO-ME 患者的 BCVA 与 OCT 和 FA 解剖特征之间存在重要的临床相关关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/3e2d5d00eb45/nihms-1871173-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/d9baa1dfbab9/nihms-1871173-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/e63e87770520/nihms-1871173-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/848f0c5f138d/nihms-1871173-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/3e2d5d00eb45/nihms-1871173-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/d9baa1dfbab9/nihms-1871173-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/e63e87770520/nihms-1871173-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/848f0c5f138d/nihms-1871173-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/9927025/3e2d5d00eb45/nihms-1871173-f0004.jpg

相似文献

1
Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion.与视网膜静脉阻塞相关的黄斑水肿的解剖学生物标志物。
Ophthalmol Retina. 2022 Dec;6(12):1206-1220. doi: 10.1016/j.oret.2022.06.016. Epub 2022 Jun 30.
2
Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis.视网膜静脉阻塞、糖尿病性和葡萄膜炎性黄斑水肿的视力:中心凹下视网膜厚度和椭圆体带分析。
Ophthalmol Retina. 2021 Jul;5(7):633-647. doi: 10.1016/j.oret.2020.10.016. Epub 2020 Oct 29.
3
Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.雷珠单抗治疗视网膜静脉阻塞所致黄斑水肿后视力预后的频域光学相干断层扫描预测指标
Ophthalmol Retina. 2020 Jan;4(1):67-76. doi: 10.1016/j.oret.2019.08.009. Epub 2019 Aug 28.
4
Predictors of Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion.抗血管内皮生长因子治疗继发于视网膜中央静脉阻塞的黄斑水肿的视力结果预测因素。
Ophthalmol Retina. 2021 Nov;5(11):1115-1124. doi: 10.1016/j.oret.2021.02.008. Epub 2021 Feb 19.
5
Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant.接受地塞米松植入物治疗的视网膜静脉阻塞继发黄斑水肿患者的光学相干断层扫描生物标志物。
BMC Ophthalmol. 2022 Apr 26;22(1):191. doi: 10.1186/s12886-022-02415-w.
6
Visual Outcomes Associated With Patterns of Macular Edema Resolution in Central Retinal Vein Occlusion Treated With Anti-Vascular Endothelial Growth Factor Therapy: A Post Hoc Analysis of the Lucentis, Eylea, Avastin in Vein Occlusion (LEAVO) Trial.抗血管内皮生长因子治疗中心性视网膜静脉阻塞后黄斑水肿消退模式与视力结局的相关性:Lucentis、Eylea、Avastin 治疗静脉阻塞(LEAVO)试验的事后分析。
JAMA Ophthalmol. 2022 Feb 1;140(2):143-150. doi: 10.1001/jamaophthalmol.2021.5619.
7
Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial.散射光凝术不能减轻视网膜静脉阻塞患者的黄斑水肿或治疗负担:RELATE试验
Ophthalmology. 2015 Jul;122(7):1426-37. doi: 10.1016/j.ophtha.2015.04.006. Epub 2015 May 9.
8
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.预测因子分析:玻璃体内注射贝伐单抗治疗视网膜分支静脉阻塞所致黄斑水肿的功能改善。
Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18.
9
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.Faricimab 治疗视网膜静脉阻塞所致黄斑水肿的疗效和安全性:BALATON 和 COMINO 试验的 24 周结果。
Ophthalmology. 2024 Aug;131(8):950-960. doi: 10.1016/j.ophtha.2024.01.029. Epub 2024 Jan 26.
10
Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT.中心凹小凹区厚度变化与视网膜静脉阻塞所致黄斑水肿视力变化的相关性:COPERNICUS、GALILEO 和 VIBRANT 的事后分析。
Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3799-3807. doi: 10.1007/s00417-022-05697-4. Epub 2022 Jun 24.

引用本文的文献

1
Exploring the role of hyperreflective walls as a biomarker for the management of cystoid macular edema.探索高反射壁作为黄斑囊样水肿管理生物标志物的作用。
Int J Ophthalmol. 2025 Sep 18;18(9):1697-1704. doi: 10.18240/ijo.2025.09.11. eCollection 2025.
2
Computational Retinal Microvascular Biomarkers from an OCTA Image in Clinical Investigation.临床研究中基于光学相干断层扫描血管造影(OCTA)图像的视网膜微血管计算生物标志物
Biomedicines. 2024 Apr 15;12(4):868. doi: 10.3390/biomedicines12040868.
3
OCTDL: Optical Coherence Tomography Dataset for Image-Based Deep Learning Methods.

本文引用的文献

1
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema.光学相干断层扫描在葡萄膜炎性黄斑水肿中的解剖和时间生物标志物。
Am J Ophthalmol. 2022 May;237:310-324. doi: 10.1016/j.ajo.2021.10.024. Epub 2021 Nov 3.
2
Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis.视网膜静脉阻塞、糖尿病性和葡萄膜炎性黄斑水肿的视力:中心凹下视网膜厚度和椭圆体带分析。
Ophthalmol Retina. 2021 Jul;5(7):633-647. doi: 10.1016/j.oret.2020.10.016. Epub 2020 Oct 29.
3
Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
OCTDL:基于图像的深度学习方法的光学相干层析成像数据集。
Sci Data. 2024 Apr 11;11(1):365. doi: 10.1038/s41597-024-03182-7.
雷珠单抗治疗视网膜静脉阻塞所致黄斑水肿后视力预后的频域光学相干断层扫描预测指标
Ophthalmol Retina. 2020 Jan;4(1):67-76. doi: 10.1016/j.oret.2019.08.009. Epub 2019 Aug 28.
4
Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.VISTA研究中糖尿病性黄斑水肿的光学相干断层扫描高阶评估:椭圆体带动态变化与视网膜液体指数
Ophthalmol Retina. 2019 Dec;3(12):1056-1066. doi: 10.1016/j.oret.2019.06.010. Epub 2019 Jul 6.
5
Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial.随机接受阿柏西普、贝伐单抗或雷珠单抗治疗的糖尿病性黄斑水肿患者在治疗期间视力变化与中心子野厚度变化之间的关联:Protocol T随机临床试验的事后分析
JAMA Ophthalmol. 2019 Sep 1;137(9):977-985. doi: 10.1001/jamaophthalmol.2019.1963.
6
Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study.脉络膜上腔注射曲安奈德治疗视网膜静脉阻塞:坦桑石研究结果
Ophthalmol Retina. 2018 Apr;2(4):320-328. doi: 10.1016/j.oret.2017.07.013. Epub 2017 Sep 29.
7
Evaluation of markers of outcome in real-world treatment of diabetic macular edema.糖尿病性黄斑水肿实际治疗中预后指标的评估
Eye Vis (Lond). 2018 Oct 11;5:27. doi: 10.1186/s40662-018-0119-9. eCollection 2018.
8
Ellipsoid Zone Mapping Parameters In Retinal Venous Occlusive Disease With Associated Macular Edema.视网膜静脉阻塞性疾病伴黄斑水肿的椭球区映射参数
Ophthalmol Retina. 2018 Aug;2(8):836-841. doi: 10.1016/j.oret.2017.11.009. Epub 2018 Jan 6.
9
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.视网膜内层结构紊乱作为静脉阻塞继发黄斑水肿患者视力的预测指标
Am J Ophthalmol. 2017 Oct;182:160-167. doi: 10.1016/j.ajo.2017.08.005. Epub 2017 Aug 22.
10
Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.视网膜疾病抗血管内皮生长因子治疗期间视力与视网膜厚度的关系
Am J Ophthalmol. 2017 Aug;180:8-17. doi: 10.1016/j.ajo.2017.05.014. Epub 2017 May 24.